[HTML][HTML] Wnt and GSK3 signaling pathways in bipolar disorder: clinical and therapeutic implications
A Muneer - Clinical Psychopharmacology and Neuroscience, 2017 - ncbi.nlm.nih.gov
The neurobiology of bipolar disorder, a chronic and systemic ailment is not completely
understood. The bipolar phenotype manifests in myriad ways, and psychopharmacological …
understood. The bipolar phenotype manifests in myriad ways, and psychopharmacological …
The Wnt signaling pathway in bipolar disorder
The Wnt signaling pathway is a highly conserved pathway critical for proper embryonic
development. However, recent evidence suggests that this pathway and one of its key …
development. However, recent evidence suggests that this pathway and one of its key …
Glycogen synthase kinase-3β as a putative therapeutic target for bipolar disorder
MP Dandekar, SS Valvassori… - Current drug …, 2018 - ingentaconnect.com
Background: Bipolar disorder (BD) is a debilitating mental ailment characterized by recurrent
episodes of mania and depression. Primary mood-stabilizing drugs like lithium and …
episodes of mania and depression. Primary mood-stabilizing drugs like lithium and …
[HTML][HTML] GSK-3 and Wnt signaling in neurogenesis and bipolar disorder
AJ Valvezan, PS Klein - Frontiers in molecular neuroscience, 2012 - frontiersin.org
The canonical Wnt signaling pathway is critical for development of the mammalian central
nervous system and regulates diverse processes throughout adulthood, including adult …
nervous system and regulates diverse processes throughout adulthood, including adult …
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
Bipolar disorder is a serious psychiatric condition that has been treated for over 50 years
with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor …
with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor …
The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder
The neurobiology of Bipolar Disorder (BD) is not completely understood, although
abnormalities in neuroplasticity and control of apoptosis have been considered as central …
abnormalities in neuroplasticity and control of apoptosis have been considered as central …
Gsk3 signalling and redox status in bipolar disorder: evidence from lithium efficacy
A Luca, C Calandra, M Luca - Oxidative medicine and cellular …, 2016 - Wiley Online Library
Objective. To discuss the link between glycogen synthase kinase‐3 (GSK3) and the main
biological alterations demonstrated in bipolar disorder (BD), with special attention to the …
biological alterations demonstrated in bipolar disorder (BD), with special attention to the …
Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding
Lithium is the most effective and well established treatment for bipolar disorder, and it has a
broad array of effects within cellular pathways. However, the specific processes through …
broad array of effects within cellular pathways. However, the specific processes through …
Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway
TD Gould, ER Dow, KC O'Donnell… - CNS & Neurological …, 2007 - ingentaconnect.com
Regulation of complex signaling pathways plays a critical role in higher-order brain
functions including the regulation of mood, cognition, appetite, sexual arousal, sleep …
functions including the regulation of mood, cognition, appetite, sexual arousal, sleep …
Glycogen synthase kinase-3: a target for novel bipolar disorder treatments
The enzyme glycogen synthase kinase-3 (GSK-3) is a direct target of lithium. While originally
recognized as an important molecule in a limited number of cellular processes, with unclear …
recognized as an important molecule in a limited number of cellular processes, with unclear …
相关搜索
- gsk 3 bipolar disorder
- wnt signaling bipolar disorder
- mood disorders wnt pathway
- gsk 3 therapeutic intervention
- pathway in schizophrenia bipolar disorder
- therapeutic mechanisms bipolar disorder
- glycogen synthase bipolar disorder
- lithium efficacy bipolar disorder
- cellular apoptosis bipolar disorder
- kinase 3β bipolar disorder
- wnt signaling cellular apoptosis
- therapeutic intervention bipolar disorder